Literature DB >> 5990443

Maculopathy a corticosteroid side-effect.

I S Jain, K Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5990443

Source DB:  PubMed          Journal:  J All India Ophthalmol Soc        ISSN： 0044-7307


× No keyword cloud information.
  12 in total

Review 1.  Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis.

Authors:  E Zamir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

Review 2.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

3.  Macular lesions during systemic therapy with depot tetracosactrin.

Authors:  J Williamson; G Nuki
Journal:  Br J Ophthalmol       Date:  1970-06       Impact factor: 4.638

4.  Six cases of central serous choroidopathy induced by systemic corticosteroid therapy.

Authors:  T Harada; K Harada
Journal:  Doc Ophthalmol       Date:  1985-08-15       Impact factor: 2.379

5.  Serum cortisol and testosterone levels in chronic central serous chorioretinopathy.

Authors:  Hasan Ali Tufan; Baran Gencer; Arzu Taskiran Comez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-21       Impact factor: 3.117

6.  Endogenous cortisol profile in patients with central serous chorioretinopathy.

Authors:  S P Garg; T Dada; D Talwar; N R Biswas
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

7.  Central serous chorioretinopathy complicating systemic corticosteroid treatment.

Authors:  M Wakakura; S Ishikawa
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

8.  Circadian disturbance and idiopathic central serous chorioretinopathy.

Authors:  Elodie Setrouk; Beatrice Hubault; Frédérique Vankemmel; Olivia Zambrowski; Pierre Nazeyrollas; Brigitte Delemer; Vincent Durlach; Alain Ducasse; Carl Arndt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-05-21       Impact factor: 3.117

9.  Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study.

Authors:  Panagiotis Karadimas; Evrydiki A Bouzas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

10.  Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment.

Authors:  B C Polak; G S Baarsma; B Snyers
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.